Item 5.07. Submission of Matters to a Vote of Security Holders.
OnMay 20, 2021 ,Harmony Biosciences Holdings, Inc. (the "Company") held its 2021 Annual Meeting of Stockholders (the "Annual Meeting"). At the Annual Meeting, stockholders voted on the following two proposals, each of which is described in detail in the Company's definitive proxy statement filed with theSecurities and Exchange Commission onApril 9, 2021 .
Proposal 1. The election of the three Class I directors listed below to serve until the Company's 2024 annual meeting of stockholders and until their successors are duly elected and qualified.
% Votes Broker Non- Votes For % Votes For Withheld Withheld Votes Jeffrey S. Aronin 35,276,131 71.6 % 13,977,307 28.4 % 806,920 R. Mark Graf 49,200,016 99.9 % 53,422 0.1 % 806,920 John C. Jacobs 39,882,314 81.0 % 9,371,124 19.0 % 806,920
Based on the votes set forth above, each of the director nominees was duly elected.
Proposal 2. The ratification of the appointment of
Votes For Votes Against Abstain 50,059,172 700 486 Based on the votes set forth above, the appointment ofDeloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year endingDecember 31, 2021 was duly ratified.
--------------------------------------------------------------------------------
© Edgar Online, source